Literature DB >> 20956209

Vascular dysfunction in women with a history of preeclampsia and intrauterine growth restriction: insights into future vascular risk.

Yoav Yinon1, John C P Kingdom, Ayodele Odutayo, Rahim Moineddin, Sascha Drewlo, Vesta Lai, David Z I Cherney, Michelle A Hladunewich.   

Abstract

BACKGROUND: Women with a history of placental disease are at increased risk for the future development of vascular disease. It is unknown whether preexisting endothelial dysfunction underlies both the predisposition to placental disease and the later development of vascular disease. The aim of this study was to assess vascular function in postpartum women and to determine whether differences emerged depending on the presentation of placental disease. METHODS AND
RESULTS: Women with a history of early-onset preeclampsia (n=15), late-onset preeclampsia (n=9), intrauterine growth restriction without preeclampsia (n=9), and prior normal pregnancy (n=16) were studied 6 to 24 months postpartum. Flow-mediated vasodilatation and flow-independent (glyceryl trinitrate-induced) vasodilatation were studied through the use of high-resolution vascular ultrasound examination of the brachial artery. Arterial stiffness was assessed by pulse-wave analysis (augmentation index). Laboratory assessment included circulating angiogenic factors (vascular endothelial growth factor, soluble fms-like tyrosine kinase 1, placental growth factor, and soluble endoglin). Flow-mediated vasodilatation was significantly reduced in women with previous early-onset preeclampsia and intrauterine growth restriction compared with women with previous late-onset preeclampsia and control subjects (3.2±2.7% and 2.1±1.2% versus 7.9±3.8% and 9.1±3.5%, respectively; P<0.0001). Flow-independent vasodilatation was similar among all groups. Similarly, the radial augmentation index was significantly increased among women with previous early-onset preeclampsia and intrauterine growth restriction, but not among late preeclamptic women and control subjects (P=0.0105). Circulating angiogenic factors were similar in all groups.
CONCLUSION: Only women with a history of early-onset preeclampsia or intrauterine growth restriction without preeclampsia exhibit impaired vascular function, which might explain their predisposition to placental disease and their higher risk of future vascular disease.

Entities:  

Mesh:

Year:  2010        PMID: 20956209     DOI: 10.1161/CIRCULATIONAHA.110.948455

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  57 in total

1.  Pregnancy: window into women's future cardiovascular health.

Authors:  Karen Fleming
Journal:  Can Fam Physician       Date:  2013-10       Impact factor: 3.275

2.  Understanding abnormal uterine artery Doppler waveforms: A novel computational model to explore potential causes within the utero-placental vasculature.

Authors:  Alys R Clark; Joanna L James; Gordon N Stevenson; Sally L Collins
Journal:  Placenta       Date:  2018-05-09       Impact factor: 3.481

Review 3.  How does preeclampsia predispose to future cardiovascular disease?

Authors:  Dawn C Scantlebury; Sharonne N Hayes
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

Review 4.  Pathophysiology of preeclampsia: an angiogenic imbalance and long-lasting systemic vascular dysfunction.

Authors:  Takuji Tomimatsu; Kazuya Mimura; Masayuki Endo; Keiichi Kumasawa; Tadashi Kimura
Journal:  Hypertens Res       Date:  2016-11-10       Impact factor: 3.872

Review 5.  Viral infections during pregnancy.

Authors:  Michelle Silasi; Ingrid Cardenas; Ja-Young Kwon; Karen Racicot; Paula Aldo; Gil Mor
Journal:  Am J Reprod Immunol       Date:  2015-01-13       Impact factor: 3.886

Review 6.  Altered Endothelial Nitric Oxide Signaling as a Paradigm for Maternal Vascular Maladaptation in Preeclampsia.

Authors:  George Osol; Nga Ling Ko; Maurizio Mandalà
Journal:  Curr Hypertens Rep       Date:  2017-09-23       Impact factor: 5.369

Review 7.  Low molecular weight heparin for the prevention of severe preeclampsia: where next?

Authors:  Kelsey McLaughlin; Ralph R Scholten; John D Parker; Enrico Ferrazzi; John C P Kingdom
Journal:  Br J Clin Pharmacol       Date:  2018-01-29       Impact factor: 4.335

Review 8.  Hypertension in pregnancy: a review of therapeutic options.

Authors:  D Kernaghan; A C Duncan; G A McKay
Journal:  Obstet Med       Date:  2012-02-17

9.  Epworth sleepiness scale scores and adverse pregnancy outcomes.

Authors:  Ghada Bourjeily; Rana El Sabbagh; Peter Sawan; Christina Raker; Carren Wang; Beth Hott; Mariam Louis
Journal:  Sleep Breath       Date:  2013-02-19       Impact factor: 2.816

Review 10.  Making cell culture more physiological: a call for a more comprehensive assessment of racial disparities in endothelial cell culture studies.

Authors:  Austin T Robinson; Marc D Cook; Abbi D Lane-Cordova
Journal:  Am J Physiol Cell Physiol       Date:  2019-11-20       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.